EPIVIR Safety Questions, EPIVIR Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about EPIVIR. Our extensive database of EPIVIR adverse events and EPIVIR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about EPIVIR

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




EPIVIR Safety Reports

Total EPIVIR reports: 215.
EPIVIR FDA safety alerts: 2003 .
Reported deaths: 20    Reported hospitalizations: 106.
Take EPIVIR Side Effects Survey or Share Your EPIVIR Story. EPIVIR Usage.

Showing 1-75 of 215 Next >

Physician from JAPAN reported EPIVIR problem on June 22, 2007. Male patient, 39 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: ascites, blood potassium decreased, convulsion, costovertebral angle tenderness, eating disorder, epilepsy, nasopharyngitis, nausea, neurogenic bladder. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZIAGEN, KALETRA. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on June 18, 2007. Male patient, 66 years of age, was diagnosed with acquired immunodeficiency syndrome, pneumocystis jiroveci pneumonia, aspergillosis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hypoacusis, otitis media, pancytopenia. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZIAGEN, RETROVIR, KALETRA, BAKTAR, BENAMBAX, FUNGUARD, GLYCEOL, DECADRON. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED KINGDOM reported EPIVIR problem on June 18, 2007. Female patient, 31 years of age, weighting 133.4 lb, was diagnosed with retroviral infection, cytomegalovirus infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with DIDANOSINE, NORVIR, FUZEON, REYATAZ, VALGANCYCLOVIR, COTRIM. Patient died.

EPIVIR problem was reported by a Physician from FRANCE on June 23, 2006. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: crepitations, nasopharyngitis, pneumonia viral, renal failure. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with KALETRA, ZERIT. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported EPIVIR problem on June 23, 2006. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, c-reactive protein increased, chills, conjunctivitis, gamma-glutamyltransferase increased, lung disorder, nasopharyngitis, pyrexia. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with KALETRA, ZERIT. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Mar 23, 2006. Male patient, 58 years of age, was diagnosed with hiv infection, nasopharyngitis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anuria, kidney fibrosis, renal arteriosclerosis, renal tubular necrosis. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, KALETRA, LOXONIN, ISALON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported EPIVIR problem on June 28, 2006. Male patient, 37 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: acid base balance abnormal, alpha 1 globulin increased, ascites, blood bicarbonate decreased, blood calcium decreased, blood chloride decreased, blood potassium decreased, blood urea decreased, blood uric acid decreased. EPIVIR dosage: unknown. During the same period patient was treated with CRIXIVAN, NORVIR, VIREAD, ZERIT, VIRACEPT, SUBUTEX, NOVOMIX, AVLOCARDYL LP. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on June 07, 2005. Male patient, 42 years of age, was diagnosed with hiv infection, factor viii deficiency and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, dehydration, faeces discoloured, gastric ulcer, gastrointestinal haemorrhage, hepatic cirrhosis, insomnia, liver disorder. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with VIDEX EC, FORTOVASE, NORVIR, REYATAZ, FACTOR VIII. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported EPIVIR problem on June 20, 2006. Female patient, child 7 years of age, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood lactic acid increased, fatigue, mitochondrial toxicity, myalgia, myocarditis, myositis, parainfluenzae virus infection. EPIVIR dosage: unknown. During the same period patient was treated with ZIAGEN, NEVIRAPINE. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on June 29, 2006. Male patient, 53 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, hepatitis b. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, ZIAGEN, ZERIT, NORVIR, REYATAZ. Patient was hospitalized and became disabled. Patient recovered.

Physician from JAPAN reported EPIVIR problem on June 29, 2006. Male patient, 46 years of age, was diagnosed with hiv infection, sciatica, hypertension, gastric ulcer and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, stent placement. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, KALETRA, NORVIR, REYATAZ, METHYCOOL, DIOVAN, MEVALOTIN, GASTER D. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on June 29, 2006. Male patient, 31 years of age, was diagnosed with hiv infection, factor viii deficiency and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: haemophilia, haemorrhagic diathesis. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, VIRACEPT, CONFACT F. Patient recovered.

Physician from JAPAN reported EPIVIR problem on June 29, 2006. Male patient, 40 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: acute abdomen, lipase increased, pancreatic enzymes increased, pancreatitis. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, REYATAZ, RETROVIR, NORVIR. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Health Professional from UNITED STATES on Mar 13, 2006. Female patient, 32 years of age, was diagnosed with hiv infection, antiviral prophylaxis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: alpha 1 foetoprotein abnormal, normal newborn, trisomy 21. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZIDOVUDINE, DIDANOSINE, NEVIRAPINE, KALETRA. Patient recovered.

Physician from JAPAN reported EPIVIR problem on July 07, 2006. Male patient, 64 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, muscular weakness. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, STOCRIN, VIREAD. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Health Professional from UNITED STATES on June 12, 2006. Female patient, 26 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abortion induced. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIREAD, REYATAZ. Patient recovered.

Physician from JAPAN reported EPIVIR problem on June 29, 2006. Male patient, 40 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute abdomen, lipase increased, pancreatic enzymes increased, pancreatitis, splenomegaly. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, REYATAZ, RETROVIR, NORVIR. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on July 13, 2006. Male patient, 44 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: epigastric discomfort, hepatic function abnormal, malaise. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZIAGEN, STOCRIN, ZITHROMAC, BAKTAR. Patient recovered.

Physician from JAPAN reported EPIVIR problem on July 18, 2006. Male patient, 57 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, hepatitis c, immune reconstitution syndrome. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZERIT, VIRACEPT, VIRAMUNE. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from JAPAN on July 17, 2006. Male patient, 53 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: acid fast bacilli infection, immune reconstitution syndrome, inflammation, lung infection, lung neoplasm, mycobacterium avium complex infection, neoplasm progression, pulmonary granuloma. EPIVIR dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on May 29, 2000. Female patient, 43 years of age, weighting 149.9 lb, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: cough, diabetes mellitus, hyperglycaemia, pneumocystis jiroveci pneumonia, pyrexia. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZIDOVUDINE, COMBIVIR, EPZICOM, VIRACEPT, BACTRIM, BENAMBAX, ZERIT, STOCRIN. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on July 28, 2006. Male patient, 55 years of age, was diagnosed with hiv infection, hypertension, hepatitis c and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic neoplasm malignant, jaundice, malignant neoplasm progression. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, VIREAD, TENORMIN, AMLODIN, RECOMBINATE, COAGULATION FACTORS, REBETOL, PEGASYS. Patient died on 08/27/2005.

Physician from JAPAN reported EPIVIR problem on July 28, 2006. Male patient, 49 years of age, was diagnosed with hiv infection, chronic hepatitis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: cerebellar haemorrhage, compression fracture, headache, nausea. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with STOCRIN, VIREAD, MONILAC, RECOMBINATE, HISHIPHAGEN C. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Male patient was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: asthenia, ear pain, myalgia, rash, rocky mountain spotted fever, therapeutic response unexpected, treatment noncompliance. EPIVIR dosage: 100MG PER DAY. During the same period patient was treated with VITAMIN B50. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported EPIVIR problem on Jan 25, 2006. Male patient, 38 years of age, was diagnosed with systemic antiviral treatment and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: asthenia, cryptococcosis, cyst, deafness, fungal infection, hypoaesthesia, immune reconstitution syndrome, intraspinal abscess, lung neoplasm. EPIVIR dosage: unknown. During the same period patient was treated with FLUCONAZOLE, STAVUDINE, INDINIVIR SULPHATE. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Aug 10, 2006. Male patient, 58 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: anaemia. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with EPZICOM, STOCRIN, TENOFOVIR DISOPROXIL FUMARATE, KALETRA, ZERIT, BACTRIM, CALCIUM LACTATE, ALFAROL. Patient died on 06/01/2005.

Consumer or non-health professional from SPAIN reported EPIVIR problem on Aug 10, 2006. Male patient, 39 years of age, was diagnosed with hiv infection, cellulitis, pain and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hepatitis c positive, hepatitis cholestatic. EPIVIR dosage: 150MG PER DAY. During the same period patient was treated with CLAMOXYL, VIRAMUNE, VIREAD, CLINDAMYCIN, IBUPROFEN. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from SWITZERLAND on Aug 03, 2006. Female patient, 17 years of age, weighting 10.00 lb, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, abnormal dreams, agitation, blood creatine phosphokinase increased, clumsiness, diarrhoea, euphoric mood, muscle spasms. EPIVIR dosage: 150 MG/ORAL. During the same period patient was treated with EFAVIRENZLET. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on July 13, 2006. Male patient, 44 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: epigastric discomfort, hepatic function abnormal, malaise. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZIAGEN, EFAVIRENZ, STOCRIN, BACTRIM, ZITHROMAC. Patient recovered.

EPIVIR problem was reported by a Physician from GERMANY on Aug 16, 2006. Female patient, 20 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: premature labour. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, ZERIT, VIRAMUNE. Patient recovered.

Physician from GERMANY reported EPIVIR problem on Aug 16, 2006. Male patient, weighting 1.54 lb, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: congenital cytomegalovirus infection, congenital hearing disorder, deafness unilateral, premature labour. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, ZERIT, VIRAMUNE. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Aug 16, 2006. Male patient, 49 years of age, was diagnosed with hiv infection, acquired immunodeficiency syndrome and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, anaemia, c-reactive protein decreased, cardiac failure congestive, decreased appetite, dyspnoea, hypertension, nasopharyngitis, nausea. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, ZIAGEN, STOCRIN, INVIRASE, NORVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported EPIVIR problem on Aug 08, 2006. Female patient, 44 years of age, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: immune reconstitution syndrome, pneumonitis cryptococcal, uveitis, vitreous disorder. EPIVIR dosage: unknown. During the same period patient was treated with NELFINAVIR MESYLATE, STAVUDINE. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Aug 16, 2006. Female patient, 21 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, pigmentation disorder, pyrexia, rash pruritic, scab. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with RETROVIR, VIRACEPT. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported EPIVIR problem on Aug 16, 2006. Female patient, 20 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: premature labour. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, ZERIT, VIRAMUNE, FOLATE. Patient recovered.

EPIVIR problem was reported by a Physician from GERMANY on Aug 16, 2006. Male patient, weighting 1.54 lb, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: congenital cytomegalovirus infection, deafness unilateral, premature labour. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, ZERIT, VIRAMUNE, FOLATE. Patient recovered.

Consumer or non-health professional from FRANCE reported EPIVIR problem on Aug 21, 2006. Male patient, 62 years of age, was diagnosed with hepatitis b and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: ascites, fatigue, hepatic atrophy, hepatic encephalopathy, hepatic failure, liver transplant, oedema peripheral, portal hypertension. EPIVIR dosage: unknown. During the same period patient was treated with ADEFOVIR DIPIVOXIL. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Aug 30, 2006. Male patient, 46 years of age, was diagnosed with acquired immunodeficiency syndrome, oesophageal candidiasis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hepatosplenomegaly, liver disorder, lymphadenitis, lymphadenopathy, lymphoma, melaena, pyrexia. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with STOCRIN, VIREAD, BACTRIM, DIFLUCAN, SELBEX, STROCAIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Sept 01, 2006. Male patient, 39 years of age, was diagnosed with hiv infection, gastritis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: renal impairment. EPIVIR dosage: unknown. During the same period patient was treated with ZERIT, VIRAMUNE, GASTER, MARZULENE S, ZIAGEN, TAKEPRON. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Sept 01, 2006. Female patient was diagnosed with hiv infection, bipolar i disorder, insomnia, pneumonia and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: back pain, compression fracture, pneumonia. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with RETROVIR, KALETRA, BEZATOL, LIMAS, DORAL, AMOBAN, GRAMALIL, CEFTRIAXONE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Oct 25, 2005. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cough, diarrhoea, dyspnoea, hypoalbuminaemia, metabolic acidosis, nephritis interstitial, nephrotic syndrome, oedema peripheral. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZIAGEN, FOSAMPRENAVIR, VIRACEPT, KALETRA, ATAZANAVIR, TENOFOVIR DISOPROXIL FUMARATE, RIBAVIRIN, INTERFERON ALFA. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from JAPAN on Aug 28, 2006. Male patient, 30 years of age, was diagnosed with hepatitis b and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: coma hepatic, enterocolitis infectious, gene mutation, hepatic failure, ileus paralytic, renal failure, respiratory failure, sepsis. EPIVIR dosage: 100 MG / PER DAY /. Patient died.

Consumer or non-health professional from UNITED STATES reported EPIVIR problem on Aug 10, 2006. Male patient was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthropod bite, asthenia, ear pain, headache, hypoaesthesia, lyme disease, myalgia. EPIVIR dosage: 150MG PER DAY. During the same period patient was treated with VITAMIN B50. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Male patient was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: adverse event, arthralgia, arthropod bite, asthenia, ear pain, headache, hypoaesthesia, lyme disease, myalgia. EPIVIR dosage: 150MG PER DAY. During the same period patient was treated with VITAMIN B50. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Sept 08, 2006. Male patient, 30 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood creatinine increased, blood lactate dehydrogenase increased, blood triglycerides increased, blood urea increased, gamma-glutamyltransferase increased. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, ZERIT, CRIXIVAN, VIRACEPT, STOCRIN, NORVIR, REYATAZ, VIREAD. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from FRANCE on Sept 08, 2006. Female patient, 45 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, normochromic normocytic anaemia, thrombocytopenia. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIDEX, SUSTIVA, PEGASYS, COPEGUS, TRUVADA. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported EPIVIR problem on Aug 16, 2006. Female patient, 20 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: premature labour. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, ZERIT, VIRAMUNE, FOLATE. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from SPAIN on Sept 07, 2006. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, c-reactive protein increased, immune reconstitution syndrome, neutrophil percentage increased, platelet count decreased, prothrombin time shortened, red blood cell sedimentation rate increased, subcutaneous abscess, transaminases increased. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, LOPINAVIR. Patient recovered.

Pharmacist from FRANCE reported EPIVIR problem on June 29, 2006. Male patient, 43 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: deafness, otosalpingitis. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZERIT, REYATAZ, CIPROFIBRATE. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from FRANCE on Sept 08, 2006. Female patient, 45 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, normochromic normocytic anaemia, thrombocytopenia. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIDEX, SUSTIVA, PEGASYS, COPEGUS, TRUVADA. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Mar 23, 2006. Male patient, 58 years of age, was diagnosed with hiv infection, nasopharyngitis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anuria, kidney fibrosis, renal arteriosclerosis, renal tubular necrosis. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, KALETRA, LOXONIN, ISALON. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Health Professional from UNITED STATES on June 12, 2006. Female patient, 26 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIREAD, REYATAZ, XANAX, IMPRAMINE, PERCOCET, ZOLOFT. Patient recovered.

Health Professional from UNITED STATES reported EPIVIR problem on June 12, 2006. Male patient was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital gastric anomaly, hydrocephalus, talipes, umbilical cord abnormality. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIREAD, REYATAZ, XANAX, IMPRAMINE, PERCOCET, ZOLOFT. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from FRANCE on Sept 25, 2006. Male patient, 45 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dehydration, renal failure acute, renal tubular disorder. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with KALETRA, VIREAD. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported EPIVIR problem on Aug 22, 2005. Female patient, 66 years of age, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, tremor. EPIVIR dosage: 100MG PER DAY. During the same period patient was treated with GLUCOTROL. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: paraesthesia. EPIVIR dosage: 100MG PER DAY. During the same period patient was treated with HYDROCHLOROTHIAZDE, FOSAMAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPIVIR problem on June 26, 2006. Female patient, 57 years of age, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: diarrhoea. EPIVIR dosage: 100MG PER DAY. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from FRANCE on Sept 08, 2006. Female patient, 45 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, normochromic normocytic anaemia, thrombocytopenia. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIDEX, SUSTIVA, PEGASYS, COPEGUS, TRUVADA. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Sept 26, 2006. Female patient, 62 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, cataract, dry eye, keratitis, vision blurred, xerophthalmia. EPIVIR dosage: unknown. During the same period patient was treated with ZERIT, NORVIR, REYATAZ, TRUVADA. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 42 years of age, was diagnosed with hiv infection, hepatitis c, factor viii deficiency and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, lactic acidosis, renal failure, sepsis, septic shock. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZERIT, INVIRASE, NEO MINOPHAGEN C. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Oct 26, 2005. Male patient, 28 years of age, was diagnosed with acquired immunodeficiency syndrome, mycobacterium avium complex infection, hepatitis c and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: haematoma evacuation, headache, hepatic function abnormal, jaundice, oral candidiasis, subdural haematoma, vomiting. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZIAGEN, NORVIR, KALETRA, ATAZANAVIR, TENOFOVIR DISOPROXIL FUMARATE, VALIXA, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from GERMANY on Sept 20, 2006. Male patient, 38 years of age, weighting 143.3 lb, was diagnosed with hepatitis chronic active, prophylaxis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, neutropenia, pneumonia, sepsis. EPIVIR dosage: 150MG PER DAY. During the same period patient was treated with RANITIDINE, IMATINIB. Patient died on 09/22/2006.

Physician from JAPAN reported EPIVIR problem on Sept 27, 2006. Male patient, 45 years of age, was diagnosed with hepatitis b and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, malaise, platelet count decreased. EPIVIR dosage: 100 MG/ PER DAY/ ORAL. During the same period patient was treated with ANTIDEPRESSANT. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 39 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetes mellitus, glycosylated haemoglobin increased, hepatic function abnormal. EPIVIR dosage: unknown. During the same period patient was treated with STAVUDINE, AMMONIUM GLYCYRRHIZATE, URSODEOXYCHOLIC ACID, FOSAMPRENAVIR, TRUVADA, FLUCONAZOLE, SAQUINAVIR CAPSULE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported EPIVIR problem on June 23, 2006. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, c-reactive protein increased, chills, conjunctivitis, gamma-glutamyltransferase increased, lung disorder, nasopharyngitis, pyrexia. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with KALETRA, ZERIT, KIVEXA. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from INDIA on Oct 03, 2006. Male patient, child 12 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: condition aggravated, immune reconstitution syndrome, lymph node tuberculosis. EPIVIR dosage: 150 MG/TWICER PER DAY/. During the same period patient was treated with EFAVIRENZ, ISONIAZID, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE, PYRAZINAMIDE, STAVUDINE. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Oct 04, 2006. Male patient, 33 years of age, was diagnosed with acquired immunodeficiency syndrome, antibiotic prophylaxis and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: anaemia, glucose tolerance impaired. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with COMBIVIR, ZERIT, VIRAMUNE, KALETRA, STOCRIN, VIREAD, KLARICID, BACTRIM. Patient was hospitalized and became disabled. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Oct 05, 2006. Female patient, 34 years of age, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity abnormal, confusional state, immune reconstitution syndrome, neuropathy peripheral, non-hodgkin's lymphoma, pallor, pleural effusion. EPIVIR dosage: unknown. During the same period patient was treated with EFAVIRENZ, STAVUDINE, TENOFOVIR. Patient died.

Consumer or non-health professional from UNITED STATES reported EPIVIR problem on Aug 10, 2006. Male patient, 72 years of age, weighting 154.3 lb, was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: adverse event, arthralgia, arthropod bite, asthenia, blood creatinine increased, blood urea increased, ear pain, headache, hypoaesthesia. EPIVIR dosage: 150MG PER DAY. During the same period patient was treated with HERBS, VITAMIN B50. Patient was hospitalized. Patient recovered.

EPIVIR problem was reported by a Physician from JAPAN on Dec 08, 2005. Male patient, 57 years of age, was diagnosed with acquired immunodeficiency syndrome, antibiotic prophylaxis, pneumonia, bacterial infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: gastric ulcer, hypoaesthesia, pancytopenia, pneumonia cytomegaloviral. EPIVIR dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZIAGEN, ZERIT, VIRACEPT, AZITHROMYCIN, FOSCAVIR, BACTRIM, PENTCILLIN. Patient died on 03/07/2005.

Physician from JAPAN reported EPIVIR problem on Oct 11, 2006. Male patient, 26 years of age, was diagnosed with hiv infection, acquired immunodeficiency syndrome, antibiotic prophylaxis, factor viii deficiency and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hyperthyroidism, malaise, weight decreased. EPIVIR dosage: unknown. During the same period patient was treated with KALETRA, VIREAD, TRUVADA, BACTRIM, ALLOPURINOL. Patient recovered.

EPIVIR problem was reported by a Consumer or non-health professional from SWEDEN on Oct 17, 2006. Female patient, 42 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, dizziness, extrasystoles, syncope, ventricular extrasystoles. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with VIREAD, REYATAZ, NORVIR, BEHEPAN, BACTRIM DS, NIFEREX. Patient recovered.

Physician from JAPAN reported EPIVIR problem on July 28, 2006. Male patient, 55 years of age, was diagnosed with hiv infection, hypertension, hepatitis c and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic neoplasm malignant, jaundice. EPIVIR dosage: unknown. During the same period patient was treated with RETROVIR, VIREAD, TENORMIN, AMLODIN, RECOMBINATE, NOVOSEVEN, REBETOL, PEGASYS. Patient died on 08/27/2005.

EPIVIR problem was reported by a Consumer or non-health professional from SPAIN on Oct 27, 2006. Female patient, 36 years of age, weighting 88.18 lb, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: hallucination. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with ZERIT, KALETRA, FOSCAVIR, SEPTRA, DIFLUCAN, MEGESTROL ACETATE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIVIR problem on Sept 08, 2006. Male patient, 30 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood creatinine increased, blood lactate dehydrogenase increased, blood triglycerides increased, blood urea increased, depression. EPIVIR dosage: 300MG PER DAY. During the same period patient was treated with RETROVIR, ZERIT, CRIXIVAN, VIRACEPT, STOCRIN, NORVIR, REYATAZ, VIREAD. Patient recovered.

Showing 1-75 of 215 Next >

Ask Our Patient Community about EPIVIR

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine